Eight antifungal agents were examined for effects on lipid biosynthesis and membrane integrity in Candida albicans. Lipids were labeled in vivo or in vitro with [14C]acetate and analyzed by thin-layer and gas chromatography. Membrane integrity was measured by a recently developed ['4C]aminoisobutyric acid radiolabel release assay. The imidazole antifungal agents miconazole, econazole, clotrimazole, and ketoconazole, at concentrations inhibiting ergosterol biosynthesis (0.1 ,uM), decreased the ratio of unsaturated to saturated fatty acids in vivo but not in vitro. Similarly, naftifine, tolnaftate, and the azasterol A25822B, at concentrations inhibiting ergosterol biosynthesis (10, 100, and 1 ,uM, respectively), decreased the ratio of unsaturated to saturated fatty acids in vivo only. This suggests that the effect on fatty acids observed with ergosterol biosynthesis inhibitors may be secondary to the effect on ergosterol. With imidazoles, oleic acid antagonized inhibition of cell growth but not inhibition of ergosterol. This suggests that, with the C-14 demethylase inhibitors, decreased unsaturated fatty acids, rather than decreased ergosterol, are responsible for growth inhibition. Cerulenin, previously reported to be a potent inhibitor of both fatty acid and ergosterol biosynthesis, was found in the present study to inhibit the former (at 5 ,uM) but not the latter (up to 100 ,uM). Of the antifungal agents tested, econazole and miconazole (at 100 ,uM) produced complete release of
benzene (42) . Lipid extracts (-200 ,000 cpm) were spotted on silica gel TLC plates and developed to half the length of the plate with chloroform-acetic acid-methanol-acetone-water (50:10:10:20:5 by volume; CAM system) (16) . The CAM system resolved phospholipids into individual species, while neutral lipids migrated with the solvent front. Plates were thoroughly dried and then developed to the full length of the plate with heptane-acetic acid-isopropyl ether (60:4:40 by volume; HAP system) (4). The HAP system resolved neutral lipids into individual classes. Alternatively, lipid extracts were spotted on two plates which were then developed in parallel to the full length of each plate with the HAP and CAM solvent systems. Lipid bands were routinely localized by overnight exposure on Kodak XAR-5 film. They were identified originally by comparison with authentic samples which were visualized by UV illumination, reaction with iodine vapor (passing air through a glass wool-plugged Pasteur pipet containing iodine crystals), or spraying with ninhydrin or antimony trichloride in chloroform (Carr-Price reagent) (15) (see Table 1 ). For quantitation, individual lipid bands were scraped into scintillation vials, mixed with 5 ml of Aquasol, and counted for radioactivity. The numbers obtained were converted to percentages of total lipids, averaged from three replicate experiments (variability, <10%), rounded to the nearest percent, and tabulated.
The Rf values of the major lipids (see Table 1 ) were as follows: phosphatidylinositol, 0.12; phosphatidylserine, 0.18; phosphatidylcholine, 0.23; and phosphatidylethanolamine, 0.45 (CAM solvent system); and ergosterol, 0.19; lanosterol, 0.25; free fatty acids, 0.44; triglycerides, 0.69; and squalene and sterol esters, 0.89 (HAP solvent system). Squalene and sterol esters could be differentiated by saponification (30% aqueous sodium hydroxide-100% ethanol [1:1 by volume]) at 55°C for 1 h.
For fatty acid analysis, whole-lipid extracts or individual lipid components extracted from the silica gel with chloroform-methanol (2:1 by volume) after preparative TLC were saponified as described above. Fatty acids were isolated by preparative TLC, extracted with chloroform-methanol, dried under nitrogen, redissolved in 0.2 ml of methanol (13 by 100 mm tubes), and esterified, after addition of 0.2 ml of methanol-sulfuric acid (80:20 by volume), for 20 h at 22°C (6) . The solution was neutralized with saturated NaHCO3 (-2 ml per tube) and extracted twice with 0.8-ml portions of ethyl ether. Extracts were dried under nitrogen and, if not analyzed immediately, were stored at -20°C. In preliminary experiments, conventional esterification with diazomethane in dry ether at 0°C (6) produced side products, at least with linolenic acid, and was subsequently abandoned.
Fatty acid methyl esters were identified by comparison with authentic samples by gas chromatography (GC), selected ion mass spectrometry, and positive chemical ionization. The quadrupole mass spectrometer was built with Extranuclear rods, electronics with a Simulscan source, and 700-and 300-liter/min diffusion pumps on the source and analyzer, respectively. A Shimadzu GC 4B was interfaced by means of 1.6-mm outside diameter glass-lined stainless steel tubing entering the source at an angle of 900 to the ion beam. The mass spectrometer was controlled by a Teknivent 69 KD computer system operating in the selected ionmonitoring mode.
The Table 2 ).
In vitro lipid biosynthesis. C. albicans was grown at 37°C in 250 ml of YECD broth until late-log phase. Cells were harvested by centrifugation and ruptured with glass beads (1 g of cells, 2 g of glass beads, 3 [18] but with the addition of 1% sodium dodecyl sulfate) (9) . After 60 min of incubation at 37°C, 5 nCi of
[14C]benzoic acid was added as an internal standard, followed by 0.75 ml of 15% potassium hydroxide in 95% ethanol to saponify lipids. The tubes were covered with steel caps and incubated at 75°C for 75 min. The mixture was neutralized with 0.4 ml of 6 N HCI, and saponified lipids were extracted with chloroform-methanol and separated on silica gel TLC (HAP solvent system). The mobility of benzoic acid was 1.2 relative to lanosterol. Fatty acids were extracted from the silica gel with chloroform-methanol, dried under nitrogen, redissolved in methanol, and esterified with methanol-sulfuric acid as described above.
Fatty acid esters were separated on a Hewlett-Packard (Palo Alto, Calif.) gas chromatograph (model 5750) equipped with a thermal conductivity detector and a Supelco 10% SP-2330 column (6 ft. [ 
RESULTS AND DISCUSSION
The lipid composition of C. albicans SC5314 is shown in Tables 1 and 2 . It was similar to that reported for C. albicans (19, 32, 45) and Saccharomyces cerevisiae (13 Table 3 ). Naftifine and tolnaftate, at 10 and 100 p.M, respectively, inhibited sterol biosynthesis by 70% and caused a 10-fold accumulation of squalene. In the case of naftifine, methylated sterols also increased, though to a lesser extent than with squalene. Squalene has been recently reported to potentiate the antifungal activity of amphotericin (22) , suggesting that naftifine and tolnaftate might also synergize with amphotericin. Naftifine is known to inhibit squalene epoxidase (30, 39) , whereas tolnaftate has been very recently suggested to act by a similar mechanism (26, 40) . Both compounds also decreased the unsaturated-to-saturated fatty acid ratio from 2.3 to 1.4. The azasterol A25822B, at 1 jiM, inhibited ergosterol biosynthesis, consistent with its reported effect on A14 reductase (12, 25, 54) . It also decreased the unsaturatedto-saturated fatty acid ratio from 2.3 to 1.3. All of the above ergosterol inhibitors caused a shift in fatty acid length from C18 to C16 (Table 3) . Some also inhibited phospholipid biosynthesis, though this effect was variable and less conclusive. Cerulenin, contrary to a previous report (27) , did not inhibit ergosterol biosynthesis up to 100 ,uM (Table 3) . It inhibited fatty acids (phospholipids and triglycerides) in vivo by over 80% at 10 F.M. The results are consistent with those from biochemical studies, in which 50% inhibitory concentrations for P-ketoacyl-acyl carrier protein synthase and 3-hydroxy-3-methylglutaryl coenzyme A synthase of 5 p.M and 1 mM have been reported (29) . The inhibitory effect of cerulenin on fatty acids is similar to that reported for other fungi (3, 27, 28) . The reported inhibition of ergosterol biosynthesis was probably inhibition of sterol ester biosynthesis secondary to inhibition of fatty acid biosynthesis. Both free ergosterol and sterol esters are precipitable by digitonin, the method used to isolate ergosterol in that study, and therefore digitonin precipitation is not a reliable index of ergosterol concentration. Moreover, stationary-phase cells, which accumulate sterol esters, were used (27) .
Lipid biosynthesis in vitro. To distinguish between primary and secondary effects on individual lipid components, an in vitro system was developed. Fatty acids were quantitated by liquid scintillation counting after GC, as described in Materials and Methods. The high background of nonradioactive fatty acids precluded quantitation by GC and mass spectrometry.
The imidazole antifungal agents naftifine, tolnaftate, and 15-azasterol inhibited ['4C]acetate incorporation into ergosterol (Table 4) . Imidazoles caused fourfold accumulation of methylated sterols, whereas naftifine and tolnaftate caused threefold accumulation of squalene at their inhibitory concentrations. For naftifine, the 50% inhibitory concentration was 100-fold higher than that reported for the isolated enzyme system (40) and similar to that for cholesterol in human fibroblasts (data not shown). There was no significant effect on individual fatty acids (Table 5) . Thus, the decrease in unsaturated fatty acids observed with these compounds in vivo was a secondary effect, probably the result of decreased It has been postulated that ergosterol has at least two types of function in membranes (37): a nonspecific, "bulk" function in the regulation of membrane fluidity and a specific, "sparking" function in the regulation of cell growth and proliferation (33, 36, 38) . Thus, compounds which inhibit ergosterol biosynthesis substantially but not completely are likely to affect membrane fluidity only. The situation is presumably corrected by exogenous fatty acids but not ergosterol because of failure of the latter to be incorporated into the membrane (17, 47) . The indirect effect of imidazoles on fungal fatty acids may explain why imidazoles are not active against bacteria unless they damage the membrane directly (44) . Their effects on mitochondrial functions, such as respiration and ATPase activity (34, 46, 49) , may be less critical to their mode of action.
As in vivo, cerulenin inhibited fatty acid biosynthesis in vitro with 50% inhibitory concentration of 5 p.M. It did not inhibit ergosterol biosynthesis up to 100 p.M.
Membrane integrity. The radiolabel release assay involves feeding cells a nonmetabolizable radioactive amino acid, treating cells with a test compound, and measuring the radioactivity remaining in the cells. The assay produced results similar to those obtained with the conventional potassium release assay (Table 6 ) but was more sensitive, accurate, convenient, and interference free. Potassium release, in turn, was more sensitive than methylene blue staining, most likely because of the smaller size of the reporter substance.
The polyenes amphotericin B and nystatin were positive in all three assays at 10 p.M and thus served as a positive control. Of the eight antifungal agents studied, miconazole and econazole were positive, though at concentrations much higher than those affecting lipid biosynthesis or cell growth (43; Table 6 ). The direct membrane effects of imidazoles (44) . Tolnaftate produced cytopathic effects in human fibroblasts at 100 ,iM (Georgopapadakou and Dix, unpublished data) but no membrane damage in C. albicans under the assay conditions, raising the possibility that squalene accumulation is toxic to cells. This may be an important point in determining whether squalene epoxidase is a clinically useful target for antifungal agents or modulators of cholesterol biosynthesis. The present studies were originally undertaken to establish convenient and unambiguous methods for determining the mode of action of novel antifungal agents. In the process, we found that brefeldin A, a C-16 fatty acid-derived cyclic antifungal agent (MIC for C. albicans, 5 jig/ml), caused membrane damage in C. albicans (50% release of [14C]aminoisobutyric acid at 2 jgl/ml). It also caused morphological changes (swelling, rounding, multiple budding in some cells) but, contrary to a previous report (11) , did not inhibit phospholipid biosynthesis. We also found tolnaftate to act similarly to naftifine and cerulenin to act exclusively through inhibition of fatty acid biosynthesis. Interestingly, in human fibroblasts cerulenin inhibited cholesterol in addition to fatty acid synthesis (Georgopapadakou and Dix, unpublished data). The effects of imidazoles on fatty acids in vivo, though secondary to ergosterol inhibition and the inability of C. albicans to take up exogenous sterols, may be responsible for growth inhibition in C. albicans.
